Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miriam Barnett
OpenAlex ID:
A5127794601
Phase 1, dose-escalation study of KTX-2001 (an NSD2 inhibitor) alone and in combination with darolutamide for metastatic castration-resistant prostate cancer.
2026
·
Wassim Abida
, Rahul Raj Aggarwal
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Show more works
View as search
Works count:
1
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
